Learning Objectives

At the end of the 2026 CRS Annual Meeting, participants will be able to:

1

Review current advances in the medical management of retinal diseases, including emerging pharmacologic therapies and evolving treatment strategies for age-related macular degeneration, diabetic macular edema, and retinal vein occlusion

2

Interpret advanced retinal imaging and clinical biomarkers to enhance diagnostic accuracy, disease monitoring, and therapeutic decision-making

3

Discuss contemporary surgical techniques and clinical decision-making in vitreoretinal surgery, including management strategies for retinal detachment, macular holes, and complex vitreoretinal conditions

4

Evaluate emerging technologies and innovations including artificial intelligence, gene therapy, and novel therapeutic platforms that may influence future clinical retina practice

Accreditation

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Ophthalmological Society (COS). You may claim a maximum of 9 hours (credits are automatically calculated). The specific opinions and content of this event are not necessarily those of COS, and are the responsibility of the organizer(s) alone.

Agenda

Friday, April 17, 2026

PLENARY SESSION #1 – SURGERY I
Cinema – first floor
Co-chairs: Bernard Hurley, MD & Keyvan Koushan, MD

3:30 PM	Welcome and Opening Remarks Co-chairs: Bernard Hurley, MD; Keyvan Koushan, MD
3:40 – 4:35 PM	Surgical Video Session: East vs West Moderators: Amin Kherani, MD and David Wong, MD
4:40 – 4:50 PM	Congenital Vitreoretinal Disorders Audina Berrocal, MD
4:52 – 5:02 PM	Power of Vitrectomy Cutter Biopsy Hung-Da Chou, MD
5:02 – 5:12 PM	Myopic Traction Maculopathy Surgery: A Beginner's Guide Hung-Da Chou, MD
5:12 – 5:30 PM	Q&A
6:00 PM	Welcome Reception – New Fort Hall

Saturday, April 18, 2026

7:00 AM

Breakfast – Princes' Gate Pre-function Area / Princes' Gate Ballroom

PLENARY SESSION #2 – ANTI-VEGF
Cinema – first floor
Moderators: TBD

8:30 – 8:35 AM	Welcome and Review of Agenda Bernard Hurley, MD; Keyvan Koushan, MD
8:35 – 8:45 AM	Biomarkers in Diabetic Macular Edema Adrian Koh Hock Chuan, MD, MBBS
8:47 – 8:55 AM	SPECTRUM: First Canadian Real‑world Outcomes with Aflibercept 8 mg in Previously Treated Diabetic Macular Edema Keyvan Koushan, MD
8:57 – 9:05 AM	Long-term Canadian Real-world Experience With Faricimab in Patients with Neovascular Age-related Macular Degeneration and Diabetic Macular Edema Parth Shah, MD
9:07 – 9:17 AM	Battle of the Next Generation Therapies John Kitchens, MD
9:19 – 9:27 AM	Aflibercept 8 mg in Retinal Vein Occlusion: Final Results from the QUASAR Study Varun Chaudhary, MD
9:29 – 9:37 AM	SPECTRUM: First Canadian Real‑world Outcomes With Aflibercept 8 mg in Previously Treated Neovascular Age-related Macular Degeneration Raman Tuli, MD
9:39 – 9:49 AM	Current Management of Polypoidal Choroidal Vasculopathy in 2026 Adrian Koh Hock Chuan, MD, MBBS
9:51 – 10:05 AM	Q&A
10:15 ‒ 11:00 AM	For more details, click here
11:00 ‒ 11:25 AM	Break – Poster Session – Princes' Gate Pre-function Area POSTER SESSION – Library Collection Lounge

PLENARY SESSION #3 – SURGERY II
Cinema – first floor
Moderators: TBD

11:30 – 11:40 AM	Lamellar Macular Holes - What's Going On and What Should We Do? David Steel, MBBS, MD(Res)
11:42 – 11:50 AM	Is 20/20 Vision Good Enough? Outcomes of Complete Pars Plana Vitrectomy During IOL Exchange for Lens Opacification in Patients with Preserved Visual Acuity Robert Gizicki, MD
11:52 AM – 12:00 PM	Suprachoroidal Viscopexy for Rhegmatogenous Retinal Detachment: Two-year Safety and Efficacy Outcomes Aurora Pecaku, MD
12:00 – 12:10 PM	Q&A
12:12 – 12:20 PM	Pneumatic Retinopexy as a Temporizing Treatment Strategy for Retinal Detachment: A Population-based Cohort Study Gareth Mercer, MD, PhD
12:22 – 12:30 PM	Vitrectomy After Successful Pneumatic Retinopexy for Rhegmatogenous Retinal Detachment Robert Gizicki, MD
12:32 – 12:42 PM	Tamponade Choice with Vitrectomy for Rhegmatogenous Retinal Detachment; Does It Make a Difference? David Steel, MBBS, MD(Res)
12:40 – 12:50 PM	Q&A
12:50 – 1:35 PM	LUNCH – Princes' Gate Pre-function Area / Princes' Gate Ballroom POSTER SESSION – Library Collection Lounge
1:35 ‒ 2:15 PM	For more details, click here

PLENARY SESSION #4 – POTPOURRI
Cinema – first floor
Moderators: TBD

2:25 – 2:35 PM	What in the World is Going on in the United States? John Kitchens, MD
2:37 – 2:45 PM	In Vivo Assessment of Peripheral Vitreous Traction with Ultra-widefield Swept-source OCT in Rhegmatogenous Retinal Detachment Isabela Martins Melo, MD
2:47 – 2:57 PM	Pediatric Retina Detachment Audina Berrocal, MD
2:57 – 3:07 PM	Q&A
3:09 – 3:19 PM	Retinopathy of Prematurity in 2026 Audina Berrocal, MD
3:21 – 3:29 PM	Comparative Outcomes of Secondary Intraocular Lens Fixation Techniques Kirill Zaslavsky, MD
3:31 – 3:39 PM	Comparison of Clinical Outcomes of Sutureless Flanged Intrascleral (Yamane) and Four-point Gore-Tex Suture Techniques for Intraocular Lens Fixation Robert Gizicki, MD
3:39 – 3:45 PM	Q&A
3:50 ‒ 4:35 PM	For more details, click here
4:35 – 5:00 PM	BREAK – Princes' Gate Pre-function Area / Princes' Gate Ballroom POSTER SESSION – Library Collection Lounge
5:00 – 5:45 PM	CRS Annual General Meeting
6:30 PM	RECEPTION – Princes' Gate Pre-function Area GALA – Princes' Gate Ballroom

Sunday, April 19, 2026

7:00 AM

Breakfast – Princes' Gate Pre-function Area / Princes' Gate Ballroom

PLENARY SESSION #5 – AGE-RELATED MACULAR DEGENERATION
Cinema – first floor
Moderators: TBD

8:35 – 8:45 AM	How to Assess Functional Loss and Progression in Geographic Atrophy Ursula Schmidt-Erfurth, MD
8:47 – 8:55 AM	One Year Results of a Phase 2 Pharmacodynamic Study: Subretinal Delivery of Investigational Gene Therapy Sura-vec (ABBV-RGX-314) for Neovascular Age-related Macular Degeneration Robert Gizicki, MD
8:57 – 9:05 AM	Reduction in Subretinal Hyperreflective Material Volume with Faricimab vs Aflibercept 2 mg in Treatment-naïve Neovascular Age-related Macular Degeneration: A TENAYA/LUCERNE Post Hoc Analysis Nirojini Sivachandran, MD, PhD
9:05 – 9:10 AM	Q&A
9:10 – 9:20 AM	How do You Diagnose Polypoidal Choroidal Vasculopathy Without Indocyanine Green Angiography? Adrian Koh Hock Chuan, MD, MBBS
9:22 – 9:30 AM	Avacincaptad Pegol for Geographic Atrophy: 3.5-Year Results from the GATHER2 Open-label Extension Trial Varun Chaudhary, MD
9:32 – 9:42 AM	Age-related Macular Degeneration as a Complex Disease Between Atrophy and Neovascularization Ursula Schmidt-Erfurth, MD
9:42 – 10:00 AM	Q&A
10:00 – 10:30 AM	BREAK – Princes' Gate Pre-function Area / Princes' Gate Ballroom POSTER SESSION – Library Collection Lounge

PLENARY SESSION #6 – Artificial Intelligence
Cinema – first floor
Moderators: TBD

10:32 – 10:42 AM	Practical Ways to Use Existing AI in Clinic David Steel, MBBS, MD(Res)
10:44 – 10:52 AM	Baseline Peripheral Vascular Leakage is Linked to Treatment Response in Patients With Central Retinal Vein Occlusion: A Pilot Study Alan Cruess, MD
10:54 – 11:04 AM	AI as a Management Tool for Neovascular Age-related Macular Degeneration Ursula Schmidt-Erfurth, MD
11:04 – 11:20 AM	Q&A

PLENARY SESSION #7 – Surgery III
Cinema – first floor
Moderators: TBD

11:25 – 11:35 AM	How Should We Treat Refractory Macular Holes? David Steel, MBBS, MD(Res)
11:37 – 11:44 AM	Predictors of Primary Anatomic Reattachment With Pneumatic Retinopexy for Rhegmatogenous Retinal Detachment Aurora Pecaku, MD
11:46 – 11:54 AM	Outer Retinal Corrugations Indicate Retinal Break Status in Rhegmatogenous Retinal Detachment Jeffrey Mah, MD
11:56 AM – 12:06 PM	Double the Adjuncts, Double the Confidence in Macular Surgery Hung-Da Chou, MD
12:06 – 12:20 PM	Q&A
12:20 PM	Concluding Remarks Bernard Hurley, MD, and Keyvan Koushan, MD
12:30 PM	GRAB & GO LUNCH (LOCATED OUTSIDE CINEMA)

Annual Meeting Agenda

All Sessions: Cinema - Ground Floor

Note: this meeting will take place in English.

Guest Speakers:

Robyn Guymer, AM, MBBS, PhD, FRANZCO, FAHMS
Professor of Ophthalmology
Melbourne University
Deputy Director
Centre for Eye Research Australia
Melbourne, Victoria, Australia

Sobha Sivaprasad, MBBS, FRCS, FRCOphth
Medical Retina Consultant Ophthalmologist
Moorfields Eye Hospital NHS Foundation Trust
Professor in Retinal Clinical Research
University College London
London, United Kingdom

Carl D. Regillo, MD, FASRS
Professor of Ophthalmology
Thomas Jefferson University
Chief, Retina Service, and Founder
Wills Eye Clinical Retina Research Unit, Wills Eye Hospital

Sunil K. Srivastava, MD
Staff Physician
Cole Eye Institute, Cleveland Clinic
Cleveland, Ohio

Friday, May 12

PLENARY SESSION #1 – COAST-TO-COAST RETINA CHECKUP PART 1 SURGERY
Moderators: Bernard Hurley, MD, and Robert Gizicki, MD

3:30 pm Welcome and Opening Remarks

3:40 pm Vitreoretinal Surgical Video Session: “Masters of Disasters”
David Wong, MD
Q&A (included)

4:25 pm Vitreoretinal Surgery in Uveitis
Sunil Srivastava, MD

4:40 pm Q&A Session

4:45 pm Pearls in Pediatric Retina Surgery
Cynthia Qian, MD

4:51 pm Complex Vitreoretinal Surgery
Flavio Rezende, MD, PhD

4:57 pm Bacillary Layer Detachment in the Pathophysiology of Secondary Macular Hole in Fovea-off Rhegmatogenous Retinal Detachment
Isabela M. Melo, MD

5:03 pm Q&A

5:11 pm Efficacy and Safety of Proposed MYL-1701P Biosimilar Compared to Eylea® (Reference Aflibercept) in Diabetic Macular Edema: A Randomized, Double-masked, Phase 3 Equivalence Study (INSIGHT Study)
Susan B. Bressler, MD

5:17 pm 2-Year Evaluation of Subretinal Fluid Drainage Techniques in Pars Plana Vitrectomy for Primary Rhegmatogenous Retinal Detachment
(ELLIPSOID-2 Study)
Aditya Bansal, MD

5:23 pm Lenses for Pars Plana Scleral Fixation
Amar Mannina, MD

5:29 pm Q&A

5:37 pm Session 1 Concluding Remarks
Moderators: Bernard Hurley, MD, and Robert Gizicki, MD

6:00 pm Welcome Reception - Princes' Gates Ballroom

Saturday, May 13

7:00 am BREAKFAST – Princes’ Gates Ballroom

7:30 am SATELLITE SYMPOSIUM – Cinema Ground Floor

PLENARY SESSION #2 – AGE-RELATED MACULAR DEGENERATION & DIABETIC MACULAR EDEMA
Moderators: Varun Chaudhary, MD, and Jason Noble, MD

8:30 am Introduction to Section 2

8:40 am Reticular Pseudodrusen – A Critical Phenotype
Robyn Guymer, AM, PhD

8:55 am Q&A

9:02 am Tyrosine Kinase Inhibition for nAMD Clinical Trial Studies
Carl Regillo, MD

9:17 am Q&A

9:24 am Early OCT Signs of Atrophy in AMD
Robyn Guymer, AM, PhD

9:39 am Q&A

9:46 am Translating Clinical Trials to Practice in Geographic Atrophy
Sobha Sivaprasad, MBBS

10:01 am Q&A

10:08 am VOYAGER: An Innovative Real-world Study of Faricimab and the Port Delivery System with Ranibizumab in Patients with nAMD and DME
Robyn Guymer, AM, PhD

10:23 am Q&A

10:30 am BREAK – Princes’ Gates Ballroom Pre-function Area, 3^rd Floor
Poster Session

PLENARY SESSION #3 – Retinal Vascular Disease
Moderators: Bernard Hurley, MD, and Robert Gizicki, MD

11:00 am Introduction to Session 3

11:05 am Choice of Agent in CRVO
Sobha Sivaprasad, MBBS

11:15 am Q&A

11:22 am CRAO Management and CRAO Masquerades
Sunil Srivastava, MD

11:37 am Q&A

11:44 am Where Do We Place Biosimilars in Our DME Treatment Algorithm?
Sobha Sivaprasad, MBBS

12:00 pm Q&A

12:07 pm Discontinuous Versus Continuous Treatment for DME: Evidence Review and Evidence Generation
Varun Chaudhary, MD

12:22 pm Q&A

12:30 pm LUNCH – Princes’ Gates Ballroom

1:15 pm SATELLITE SYMPOSIUM – Cinema Ground Floor

PLENARY SESSION #4 – Surgery
Moderator: Bernard Hurley, MD, and Wai-Ching Lam, MD

2:15 pm Introduction to Session 4

2:20 pm Perfluorocarbon Liquid in Retinal Detachment Repair: Pearls and Pitfalls
Carl Regillo, MD

2:35 pm Q&A

2:42 pm Mila Oh Memorial Lecture: Diagnosis and Management of Diabetic Retinopathy in 2030
Sobha Sivaprasad, MBBS

2:57 pm Q&A

3:04 pm The Surgical Management of Inherited Retinal Diseases
Peter Kertes, MD

3:19 pm Q&A

3:26 pm Gene Therapy for Neovascular AMD and Diabetic Retinopathy
Carl Regillo, MD

3:41 pm Q&A

3:48 pm BREAK – Princes’ Gates Ballroom Pre-function Area, 3^rd Floor
Poster Session

PLENARY SESSION #5 – Uveitis
Moderators: Phil Hooper, MD, and Robert Gizicki, MD

4:15 pm Introduction to Session 5

4:25 pm Masquerade Syndromes, New Treatment in Uveitis Imaging
Sunil Srivastava, MD

4:40 pm Q&A

4:47 pm Clinical and Imaging Pearls in Uveitis
Nupura Bakshi, MD

5:02 pm Q&A

5:15-6:00 pm CRS Annual General Meeting – Cinema Ground Floor

6:30 pm GALA – Princes’ Gates Ballroom

Sunday, May 14

7:30 am BREAKFAST

PLENARY SESSION #6 – Coast-to-Coast Part 2 Medical Retina
Moderators: Bernard Hurley, MD, and Robert Gizicki, MD

8:45 am Introduction to Session 6

8:50 am Pachychoroid Spectrum Diseases
Wai-Ching Lam, MD

8:56 am Scleral Buckle Techniques
Geoff Williams, MD

9:02 am Exciting and New
Mark Greve, MD

9:08 am Does Anti-VEGF Treatment Impact Retinal Nonperfusion in Diabetic Retinopathy?
Varun Chaudhary, MD

9:14 am Q&A

9:30 am SPONSORED SYMPOSIUM – Cinema Ground Floor

10:30 am BREAK – Trillium Park Studio, 3^rd Floor
Poster Session

10:45 am Assessment of Geographic Atrophy Progression in the Phase 3 OAKS and DERBY Trials
Tom Sheidow, MD

10:51 am Retinal Displacement After Scleral Buckle Versus Combined Buckle and Vitrectomy for Rhegmatogenous Retina Detachment: ALIGN SB vs PPV-SB
Aditya Bansal, MD

10:57 am The Long-term Structural and Functional Impact of Retinopathy of Prematurity
Cynthia Qian, MD

11:03 am Delayed Near InfraRed Analysis (DNIRA) Identifies Novel Features of Nonexudative (Dry) AMD in a Prospective, Natural History Study
Filiberto Altomare, MD

11:09 am Q&A

11:24 am Concluding Remarks
Co-chairs: Bernard Hurley, MD, and Robert Gizicki, MD

12:00 pm LUNCH – Princes’ Gates Ballroom

Poster Presenters

Isabela M. Melo, MD – Toronto, ON

Posterior Hyaloid Discontinuity on Optical Coherence Tomography in Partial Posterior Vitreous Detachment and Vitreomacular Traction
Impact of Baseline Morphological Stage on Post-operative Outcomes in Rhegmatogenous Retinal Detachment

Parnian Arjmand, MD – Toronto, ON

Juxtafoveal Retinal Arterial Macroaneurysm: The Role of Ancillary Imaging

Amin Kherani, MD – Calgary, AB

Intraocular foreign body injuries from a Calgary perspective – a retrospective case series

Carl Shen, MD – Hamilton, ON

Intraretinal silicone oil migration: An under recognized OCT phenotype

Paola Oquendo, MD – Hamilton, ON

Comparison of the Photoreceptor Mosaic Before and After Macular Hole Surgery with High Resolution Adaptive Optics Imaging
Epiretinal Membrane and Associated Tractional Abnormalities Following Rhegmatogenous Retinal Detachment Repair

Hatim Batawi, MD – Toronto, ON

Outer Retinal Hyperreflective Dots, A Potential Biomarker in Rhegmatogenous Retinal Detachment

Khaldon Abbas – Vancouver, BC

Characteristics of No-show appointments at a multicenter retina subspeciality practice

Aurora Pecaku, MD – Toronto, ON

Reattachment Rate with Pneumatic Retinopexy vs Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment with a Single Break in Detached Retina Only

Irina Sverdlichenko – Toronto, ON

Macular Hole Associated Retinal Detachment in High Myopic Patients: Case series and Overview of a Novel Surgical Technique

Aaditeya Jhaveri – Toronto, ON

Optical coherence tomography biomarkers as potential predictors for visual function and response to intravitreal therapy in diabetic macular edema: a review

Fowad Daud – Hamilton, ON

Combined versus Sequential Pars Plana Vitrectomy and Phacoemulsification for Macular Hole and Epiretinal Membrane – A Systematic Review and Meta-Analysis

Milena Cioana – Toronto, ON

Post-procedural endophthalmitis visual outcomes by microorganism: A systematic review and meta-analysis